Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian Seal

Showing results (1-10 of 58) with videos related to

Pageof 6
Sort By:
Expert Review of Pharmacoeconomics & Outcomes Research|June 10, 2010
Pharmacoeconomics of levocetirizine in allergic rhinitis and chronic idiopathic urticaria: considerations for the USALawrence M Dubuske, Brian Seal, Martin Cj Brown
Postgraduate Medicine|July 3, 2013
Impact of metastatic colorectal cancer stage and number of treatment courses on patient health care costs and utilizationBenjamin Chastek, Mahesh Kulakodlu, Satish Valluri, et al.
Hepatic Oncology|August 19, 2021
Locoregional therapy patterns and healthcare economic burden of patients with hepatocellular carcinoma in the USAAbdalla Aly, Melissa Lingohr-Smith, Jay Lin, et al.
Current Medical Research and Opinion|June 18, 2009
Insomnia-related comorbidities and economic costs among a commercially insured population in the United StatesMichael Pollack, Brian Seal, Vijay N Joish, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 31, 2010
Chemotherapy and survival benefit in elderly patients with advanced non-small-cell lung cancerAmy J Davidoff, Mei Tang, Brian Seal, et al.
American Health & Drug Benefits|August 16, 2014
Economic Evaluation of Quality-of-Life Improvement with Second-Generation Antihistamines and Montelukast in Patients with Allergic RhinitisKim R Saverno, Brian Seal, Michael J Goodman, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|December 1, 2010
Economic comparison of rasburicase and allopurinol for treatment of tumor lysis syndrome in pediatric patientsMichael Eaddy, Brian Seal, Muralikrishna Tangirala, et al.
BMC Medical Research Methodology|January 4, 2014
Concordance between administrative claims and registry data for identifying metastasis to the bone: an exploratory analysis in prostate cancerEberechukwu Onukwugha, Candice Yong, Arif Hussain, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|March 5, 2011
Population-based estimates of survival benefit associated with combined modality therapy in elderly patients with locally advanced non-small cell lung cancerAmy J Davidoff, James F Gardner, Brian Seal, et al.
Urology|February 19, 2010
Health disparities in staging of SEER-medicare prostate cancer patients in the United StatesC Daniel Mullins, Eberechukwu Onukwugha, Kaloyan Bikov, et al.
Pageof 6

Showing results (1-10 of 58) with videos related to

Sort By:
Pageof 6
Expert Review of Pharmacoeconomics & Outcomes Research|June 10, 2010
Pharmacoeconomics of levocetirizine in allergic rhinitis and chronic idiopathic urticaria: considerations for the USALawrence M Dubuske, Brian Seal, Martin Cj Brown
Postgraduate Medicine|July 3, 2013
Impact of metastatic colorectal cancer stage and number of treatment courses on patient health care costs and utilizationBenjamin Chastek, Mahesh Kulakodlu, Satish Valluri, et al.
Hepatic Oncology|August 19, 2021
Locoregional therapy patterns and healthcare economic burden of patients with hepatocellular carcinoma in the USAAbdalla Aly, Melissa Lingohr-Smith, Jay Lin, et al.
Current Medical Research and Opinion|June 18, 2009
Insomnia-related comorbidities and economic costs among a commercially insured population in the United StatesMichael Pollack, Brian Seal, Vijay N Joish, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 31, 2010
Chemotherapy and survival benefit in elderly patients with advanced non-small-cell lung cancerAmy J Davidoff, Mei Tang, Brian Seal, et al.
American Health & Drug Benefits|August 16, 2014
Economic Evaluation of Quality-of-Life Improvement with Second-Generation Antihistamines and Montelukast in Patients with Allergic RhinitisKim R Saverno, Brian Seal, Michael J Goodman, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|December 1, 2010
Economic comparison of rasburicase and allopurinol for treatment of tumor lysis syndrome in pediatric patientsMichael Eaddy, Brian Seal, Muralikrishna Tangirala, et al.
BMC Medical Research Methodology|January 4, 2014
Concordance between administrative claims and registry data for identifying metastasis to the bone: an exploratory analysis in prostate cancerEberechukwu Onukwugha, Candice Yong, Arif Hussain, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|March 5, 2011
Population-based estimates of survival benefit associated with combined modality therapy in elderly patients with locally advanced non-small cell lung cancerAmy J Davidoff, James F Gardner, Brian Seal, et al.
Urology|February 19, 2010
Health disparities in staging of SEER-medicare prostate cancer patients in the United StatesC Daniel Mullins, Eberechukwu Onukwugha, Kaloyan Bikov, et al.
Pageof 6